Sign up for a free trial now

Login
Subscribe
Take a FREE Trial

About Us
Contact us
RSS

20 May 2013

Search

The Pharma Letter

Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe

Ossianix Articles

There are no articles related to Ossianix.

Hot Topics
Most Read

Elan makes "transformational" acquisitions and a divestment
Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
SciClone gains China rights to Zensun's Neucardin
Bristol-Myers' data on Yervoy and nivolumab causes a stir
Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member

Elan makes "transformational" acquisitions and a divestment
Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
SciClone gains China rights to Zensun's Neucardin
Bristol-Myers' data on Yervoy and nivolumab causes a stir
Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member

© 2013 thepharmaletter.com

Home
RSS
About Us
Subscribe
Terms and Conditions
Article Archive

Site powered by WORKSsitebuilder CMS